{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:09:29Z","timestamp":1790730569444,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00415-022-11162-3","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T20:08:43Z","timestamp":1653077323000},"page":"5061-5069","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies"],"prefix":"10.1007","volume":"269","author":[{"given":"D\u00e9borah","family":"Guery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Cousyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bani-Sadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Shor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Mu\u00f1iz-Castrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-8515","authenticated-orcid":false,"given":"Sylvain","family":"Rheims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"11162_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F (2017) Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev 97:839\u2013887. https:\/\/doi.org\/10.1152\/physrev.00010.2016","journal-title":"Physiol Rev"},{"key":"11162_CR2","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain J Neurology 133:2734\u20132748. https:\/\/doi.org\/10.1093\/brain\/awq213","journal-title":"Brain J Neurology"},{"key":"11162_CR3","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, Thijs RD, Coenders EC et al (2016) Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 87:1449\u20131456. https:\/\/doi.org\/10.1212\/WNL.0000000000003173","journal-title":"Neurology"},{"key":"11162_CR4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","volume":"69","author":"SR Irani","year":"2011","unstructured":"Irani SR, Michell AW, Lang B et al (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69:892\u2013900. https:\/\/doi.org\/10.1002\/ana.22307","journal-title":"Ann Neurol"},{"key":"11162_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/brain\/aww012","volume":"139","author":"V Navarro","year":"2016","unstructured":"Navarro V, Kas A, Apartis E et al (2016) Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain J Neurology 139:1079\u20131093. https:\/\/doi.org\/10.1093\/brain\/aww012","journal-title":"Brain J Neurology"},{"key":"11162_CR6","doi-asserted-by":"publisher","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","volume":"92","author":"MAAM de Bruijn","year":"2019","unstructured":"de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH et al (2019) Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis. Neurol 92:e2185\u2013e2196. https:\/\/doi.org\/10.1212\/WNL.0000000000007475","journal-title":"Neurol"},{"key":"11162_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/brain\/awx323","volume":"141","author":"J Thompson","year":"2018","unstructured":"Thompson J, Bi M, Murchison AG et al (2018) The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain J Neurol 141:348\u2013356. https:\/\/doi.org\/10.1093\/brain\/awx323","journal-title":"Brain J Neurol"},{"key":"11162_CR8","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/brain\/awt212","volume":"136","author":"SR Irani","year":"2013","unstructured":"Irani SR, Stagg CJ, Schott JM et al (2013) Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain J Neurol 136:3151\u20133162. https:\/\/doi.org\/10.1093\/brain\/awt212","journal-title":"Brain J Neurol"},{"key":"11162_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012465.10.1212\/WNL.0000000000012465","author":"KM Smith","year":"2021","unstructured":"Smith KM, Dubey D, Liebo GB et al (2021) Clinical course and features of seizures associated With LGI1-Antibody encephalitis. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000012465.10.1212\/WNL.0000000000012465","journal-title":"Neurology"},{"key":"11162_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108159","volume":"122","author":"N Lin","year":"2021","unstructured":"Lin N, Liu Q, Chen J et al (2021) Long-term seizure outcomes in patients with anti-leucine-rich glioma-inactivated 1 encephalitis. Epilepsy Behav 122:108159. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108159","journal-title":"Epilepsy Behav"},{"key":"11162_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000974","volume":"8","author":"S Mu\u00f1iz-Castrillo","year":"2021","unstructured":"Mu\u00f1iz-Castrillo S, Haesebaert J, Thomas L et al (2021) Clinical and prognostic value of immunogenetic characteristics in anti-LGI1 encephalitis. Neurology 8:e974. https:\/\/doi.org\/10.1212\/NXI.0000000000000974","journal-title":"Neurology"},{"key":"11162_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.seizure.2021.02.010","volume":"86","author":"M Ilyas-Feldmann","year":"2021","unstructured":"Ilyas-Feldmann M, Pr\u00fc\u00df H, Holtkamp M (2021) Long-term seizure outcome and antiseizure medication use in autoimmune encephalitis. Seizure 86:138\u2013143. https:\/\/doi.org\/10.1016\/j.seizure.2021.02.010","journal-title":"Seizure"},{"key":"11162_CR13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/epi.16571","volume":"61","author":"C Steriade","year":"2020","unstructured":"Steriade C, Britton J, Dale RC et al (2020) Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions. Epilepsia 61:1341\u20131351. https:\/\/doi.org\/10.1111\/epi.16571","journal-title":"Epilepsia"},{"key":"11162_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.12.010","volume":"129","author":"M Carre\u00f1o","year":"2017","unstructured":"Carre\u00f1o M, Bien CG, Asadi-Pooya AA et al (2017) Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies. Epilepsy Res 129:101\u2013105. https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.12.010","journal-title":"Epilepsy Res"},{"key":"11162_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1684\/epd.2012.0515","volume":"14","author":"V Almeida","year":"2012","unstructured":"Almeida V, Pimentel J, Campos A et al (2012) Surgical control of limbic encephalitis associated with LGI1 antibodies. Epileptic Disord Int Epilepsy J Videotape 14:345\u2013348. https:\/\/doi.org\/10.1684\/epd.2012.0515","journal-title":"Epileptic Disord Int Epilepsy J Videotape"},{"key":"11162_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000974","author":"S Mu\u00f1iz-Castrillo","year":"2021","unstructured":"Mu\u00f1iz-Castrillo S, Haesebaert J, Thomas L, Vogrig A, Pinto AL, Picard G, Blanc C, Do LD, Joubert B, Berzero G, Psimaras D (2021) Clinical and prognostic value of immunogenetic characteristics in anti-LGI1 encephalitis. Neurol-Neuroimmunol Neuroinflammn. https:\/\/doi.org\/10.1212\/NXI.0000000000000974","journal-title":"Neurol-Neuroimmunol Neuroinflammn"},{"key":"11162_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra1004418","volume":"365","author":"P Kwan","year":"2011","unstructured":"Kwan P, Schachter SC, Brodie MJ (2011) Drug-resistant epilepsy. N Engl J Med 365:919\u2013926. https:\/\/doi.org\/10.1056\/NEJMra1004418","journal-title":"N Engl J Med"},{"key":"11162_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D et al (2015) A definition and classification of status epilepticus\u2014Report of the ILAE task force on classification of status epilepticus. Epilepsia 56:1515\u20131523. https:\/\/doi.org\/10.1111\/epi.13121","journal-title":"Epilepsia"},{"key":"11162_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327302","author":"A Rodriguez","year":"2021","unstructured":"Rodriguez A, Klein CJ, Sechi E et al (2021) LGI1 antibody encephalitis: acute treatment comparisons and outcome. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2021-327302","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11162_CR20","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/acn3.51137","volume":"7","author":"C Shen","year":"2020","unstructured":"Shen C, Fang G, Yang F et al (2020) Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA B R encephalitis. Ann Clin Transl Neurol 7:1392\u20131399. https:\/\/doi.org\/10.1002\/acn3.51137","journal-title":"Ann Clin Transl Neurol"},{"key":"11162_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10250-6","author":"A Rada","year":"2020","unstructured":"Rada A, Birnbacher R, Gobbi C et al (2020) Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term data. J Neurol. https:\/\/doi.org\/10.1007\/s00415-020-10250-6","journal-title":"J Neurol"},{"key":"11162_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/epi4.12226","volume":"3","author":"AM Feyissa","year":"2018","unstructured":"Feyissa AM, Lamb C, Pittock SJ et al (2018) Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1. Epilepsia Open 3:348\u2013356. https:\/\/doi.org\/10.1002\/epi4.12226","journal-title":"Epilepsia Open"},{"key":"11162_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10642-2","author":"P Lardeux","year":"2021","unstructured":"Lardeux P, Fourier A, Peter E et al (2021) Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis. J Neurol. https:\/\/doi.org\/10.1007\/s00415-021-10642-2","journal-title":"J Neurol"},{"key":"11162_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12883-019-1396-1","volume":"19","author":"Y-O Liu","year":"2019","unstructured":"Liu Y-O, Zhou W-J, Hong B et al (2019) Surgical outcomes in patients with epilepsy after viral encephalitis: contribution of SEEG study. BMC Neurol 19:165. https:\/\/doi.org\/10.1186\/s12883-019-1396-1","journal-title":"BMC Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11162-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11162-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11162-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T15:13:03Z","timestamp":1660057983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11162-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["11162"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11162-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"28 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest related to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}